Additional Conditions. As a condition to any such assignment or subletting, whether or not Landlord’s consent is required, Landlord may require:
Turning Point Therapeutics, Inc. (TPTX) (CIK 0001595893)
Source: SEC EDGAR database • Date: February 17, 2021 • SIC: 2834 • CIK: 2834
Atara Biotherapeutics, Inc. (ATRA) (CIK 0001604464)
Source: SEC EDGAR database • Date: May 4, 2021 • SIC: 2836 • CIK: 2836
Stoke Therapeutics, Inc. (STOK) (CIK 0001623526)
Source: SEC EDGAR database • Date: November 8, 2021 • SIC: 2834 • CIK: 2834
Eloxx Pharmaceuticals, Inc. (ELOX) (CIK 0001035354)
Source: SEC EDGAR database • Date: May 7, 2021 • SIC: 8731 • CIK: 8731
TCR2 THERAPEUTICS INC. (TCRR) (CIK 0001750019)
Source: SEC EDGAR database • Date: May 13, 2021 • SIC: 2836 • CIK: 2836
Allakos Inc. (ALLK) (CIK 0001564824)
Source: SEC EDGAR database • Date: February 25, 2020 • SIC: 2834 • CIK: 2834
Beam Therapeutics Inc. (BEAM) (CIK 0001745999)
Source: SEC EDGAR database • Date: August 12, 2020 • SIC: 2836 • CIK: 2836
CONSTELLATION PHARMACEUTICALS INC (CNST) (CIK 0001434418)
Source: SEC EDGAR database • Date: February 24, 2021 • SIC: 2834 • CIK: 2834
Nurix Therapeutics, Inc. (NRIX) (CIK 0001549595)
Source: SEC EDGAR database • Date: October 14, 2021 • SIC: 2834 • CIK: 2834
REGENXBIO Inc. (RGNX) (CIK 0001590877)
Source: SEC EDGAR database • Date: November 7, 2018 • SIC: 2836 • CIK: 2836
Next results